Gilead, Merck begin Phase 2 study of investigational HIV treatment regimen

By NS Healthcare Staff Writer

27 Oct 21

The regimen includes Merck’s nucleoside reverse transcriptase translocation inhibitor islatravir and Gilead’s potential capsid inhibitor lenacapavir

PharmaceuticalsClinical trials

Novartis’ cancer drug canakinumab fails in Phase 3 CANOPY-1 trial

By NS Healthcare Staff Writer

26 Oct 21

The Phase 3 CANOPY-1 study did not meet its primary endpoints of OS and PFS in patients with…

PharmaceuticalsClinical trials

Moderna’s Covid-19 vaccine found effective in kids aged six to 11 years: Study

By NS Healthcare Staff Writer

26 Oct 21

In the Phase 2/3 study, two 50μg doses of mRNA-1273 were generally well tolerated and showed superior neutralising…

PharmaceuticalsClinical trials

Biological E seeks DGCI approval to study Corbevax as booster dose

By NS Healthcare Staff Writer

13 Oct 21

Corbevax is an RBD protein sub-unit vaccine currently under Phase 2/3 clinical trials in adults aged 18 years…

PharmaceuticalsClinical trials

Merck’s molnupiravir reduces risk of Covid-19 hospitalisation or death by half

By NS Healthcare Staff Writer

04 Oct 21

Merck intends to pursue the US FDA emergency use authorisation for the drug, and file regulatory applications with…

PharmaceuticalsClinical trials

Sanofi halts development of mRNA-based Covid-19 vaccine

By NS Healthcare Staff Writer

29 Sep 21

The company will focus on the development of adjuvanted recombinant vaccine candidate, in partnership with GlaxoSmithKline (GSK)

PharmaceuticalsClinical trials

Pfizer initiates Phase 2/3 study of potential oral Covid-19 drug

By NS Healthcare Staff Writer

28 Sep 21

EPIC-PEP study will enrol up to 2,660 healthy participants, aged 18 years and above, who live together with…

PharmaceuticalsClinical trials

Pfizer-BioNTech Covid-19 vaccine found effective in kids aged five to 11 years: Study

By NS Healthcare Staff Writer

21 Sep 21

In the trial, Comirnaty showed a neutralising antibody geometric mean titre (GMT) of 1,197.6 in children aged five…

PharmaceuticalsClinical trials

J&J’s Ebola vaccine regimen effective in adults and children, shows Phase 3 data

By NS Healthcare Staff Writer

14 Sep 21

The data was based on Phase 3 EBOVAC-Salone clinical study, in which the vaccine regimen was well-tolerated in…

PharmaceuticalsClinical trials

Biological E gets DCGI nod to study Covid-19 vaccine in children, adolescents

By NS Healthcare Staff Writer

06 Sep 21

Biological E developed Corbevax in partnership with Baylor College of Medicine and biopharmaceutical company Dynavax Technologies

PharmaceuticalsClinical trials